In a move aimed at simplifying export procedures and enhancing regulatory efficiency, the Drugs Controller General of India ...

DCGI asks manufacturers of two FDCs to submit applications within 3 months: Gireesh Babu, New Delhi Friday, February 28, 2025, 08:00 Hrs [IST] The Drugs Controller General of Indi ...

Bajaj Healthcare announced on Thursday that it has received approval from the Drug Controller General of India (DCGI) to manufacture Pimavanserin, a drug used to treat hallucinations and delusions ...

We have 10,000 plus manufacturing units, we have 10 lakh of sales outlets, we have 4,000 plus medical devices manufacturing ...

As per the definition of "New Drug" specified in Rule 2(1)(w) of the NDCT Rules, a modified or sustained release form of a drug or novel drug delivery system of any drug approved by the Central ...

DCGI has sought post-market surveillance data ... governments without due approval from the Central Licensing Authority. Post-market surveillance data is information about a drug's safety and ...

New Delhi, Mar 5 () Zydus Cadila has received approval from the Drug Controller General of India (DCGI) for its new drug application for Saroglitazar to treat a particular condition of liver ...

So far, the regulator has two approved CAR-T cell therapies, used to treat certain types of cancers ... as the Indian ...

Biophore India Pharmaceuticals on Friday said it has applied to the Drugs Controller General of India (DCGI) for obtaining emergency-use approval for Aviptadil, used in the treatment of moderate ...

Earlier this month, regulator DCGI cautioned against the consumption ... How can a medicine approved by the drug control authority be banned, Delhi High Court asked today, as the government ...